Drug Search Results
More Filters [+]

Astodrimer

Alternative Names: astodrimer, spl-7013, spl7013, spl 7013, vivagel
Latest Update: 2022-07-01
Latest Update Note: PubMed Publication

Product Description

Astodrimer gel is a novel drug which demonstrated favourable outcomes for treatment of patients with bacterial vaginosis. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/33749959/)

Mechanisms of Action: Bacterial Growth Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical,Vaginal,Nasal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: Starpharma Pty
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Astodrimer

Countries in Clinic: Australia

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: COVID-19

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTRN12620001371987

P1

Completed

COVID-19

2021-03-08

Recent News Events